Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
Chinmayee Choudhury, N. Arul Murugan, U. Deva Priyakumar
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1847-1861
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Artificial intelligence for natural product drug discovery
Michael W. Mullowney, Katherine Duncan, Somayah S. Elsayed, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 895-916
Closed Access | Times Cited: 159
KG-Predict: A knowledge graph computational framework for drug repurposing
Zhenxiang Gao, Pingjian Ding, Rong Xu
Journal of Biomedical Informatics (2022) Vol. 132, pp. 104133-104133
Open Access | Times Cited: 55
Computational Exploration of Anti-cancer Potential of Flavonoids against Cyclin-Dependent Kinase 8: An In Silico Molecular Docking and Dynamic Approach
Sanket Rathod, Ketaki Shinde, Jaykedar Porlekar, et al.
ACS Omega (2022) Vol. 8, Iss. 1, pp. 391-409
Open Access | Times Cited: 53
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 40
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 40
Decoding Connectivity Map-based drug repurposing for oncotherapy
Yuanchun Zhao, Xingqi Chen, Jiajia Chen, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 3
Open Access | Times Cited: 32
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
Yasir Ali, Hina Imtiaz, Tahir Muhammad, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 570-570
Open Access | Times Cited: 24
PLAS-20k: Extended Dataset of Protein-Ligand Affinities from MD Simulations for Machine Learning Applications
Divya B. Korlepara, C. S. Vasavi, Rakesh Srivastava, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 13
The next revolution in computational simulations: Harnessing AI and quantum computing in molecular dynamics
Anna Lappala
Current Opinion in Structural Biology (2024) Vol. 89, pp. 102919-102919
Closed Access | Times Cited: 9
Neuronal and Therapeutic Perspectives on Empathic Pain: A Rational Insight
Punit Prasanna Kujur, Surendar Ellappan, Amal Chandra Mondal
Neuropharmacology (2025), pp. 110414-110414
Closed Access | Times Cited: 1
New Drug Discovery
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2023), pp. 134-184
Closed Access | Times Cited: 19
Making sense of chemical space network shows signs of criticality
Nicola Amoroso, Nicola Gambacorta, Fabrizio Mastrolorito, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
The contemporary nexus of medicines security and bioprospecting: a future perspective for prioritizing the patient
Geoffrey A. Cordell
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations
Hossam Nada, Ahmed Elkamhawy, Kyeong Lee
PeerJ (2022) Vol. 10, pp. e14120-e14120
Open Access | Times Cited: 25
Computational identification of potential inhibitors targeting cdk1 in colorectal cancer
Uchechukwu Chibuzo Ogbodo, Ojochenemi A. Enejoh, Chinelo H. Okonkwo, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 11
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
AI‐Based Personalized Drug Treatment
M. Shanmuga Sundari, Harshini Reddy Penthala, Akshita Mogullapalli, et al.
(2024), pp. 369-406
Closed Access | Times Cited: 4
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
Paul Perco, Matthias Ley, Kinga Kęska‐Izworska, et al.
PROTEOMICS (2025)
Open Access
Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells
Y. Terry Lee, Chang‐Gu Hyun
Molecules (2025) Vol. 30, Iss. 4, pp. 900-900
Open Access
Computational insights into drug discovery from Vernonia amygdalina: a narrative review
Peter Chinedu Agu, Celestine O. Ogbu, Boniface Anthony Ale, et al.
Discover Plants. (2025) Vol. 2, Iss. 1
Open Access
A bibliometric review on in silico drug repurposing: Performance analysis, science mapping and text mining (2000–2023)
Alejandro I. Trejo-Castro, Emmanuel Martínez-Ledesma, Antonio Martínez‐Torteya
Heliyon (2025) Vol. 11, Iss. 10, pp. e42750-e42750
Open Access
Unveiling the influence of fastest nobel prize winner discovery: alphafold’s algorithmic intelligence in medical sciences
Niki Najafi, Reyhaneh Karbassian, Helia Hajihassani, et al.
Journal of Molecular Modeling (2025) Vol. 31, Iss. 6
Closed Access
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19
Gangireddy Navitha Reddy, Akanksha Jogvanshi, Sana Naikwadi, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 943-955
Closed Access | Times Cited: 9
The mechanistic functional landscape of retinitis pigmentosa: a machine learning-driven approach to therapeutic target discovery
Marina Esteban‐Medina, Carlos Loucera, Kinza Rian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer
Muhammad Shahab, Peng Ziyu, Muhammad Waqas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top